Wrap up: Bonqat officially commercially launched, and other veterinary news

Eva/stock.adobe.com

Happy Friday dvm360 readers! As we are preparing to leave April and head into Spring, there is a lot to look forward to from dvm360 within the next couple of months. We have Fetch Nashville that is now less than one month away and then Fetch Kansas City in August. We still have availability for both and these are 2 conferences you do NOT want to miss so learn more, register, and see what else is coming down the pipeline from Fetch here today.

In the meantime, here is what was popular this week on dvm360.com:

• Zoetis announced earlier this week that its pregabalin oral solution Bonqat, has been commercially launched and is available to veterinary clinics throughout the United States. The drug is designed for use to treat anxiety and fear in cats during travel and veterinary visits.
• On this week’s episode of The Vet Blast Podcast, host Adam Chirstman, DVM, MBA sits down Frank Bozelka, DVM, to give 5 tips to veterinary students as they prepare to graduate and enter the workforce for the first time.
• Volition Rx Limited shared the news this week that its product, Nu. Q Vet Cancer Test, is now available to veterinarians across the United States and Europe through Antech.
• A survey of over 1056 veterinarians around the world conducted Boehringer Ingelheim to investigate if veterinarians are understood by clients and feel valued found 75% feel personally appreciated by their client, but only 49% feel the profession in general is appreciated.
• Trupanion provided an overview of its topmost common claim for pets, allergies, and how it has seen an over 40% increase in the frequency of allergy and ear infection claims for pets in North America, and more.
• Bill Murray, CEO of Wicklow Healthcare Advisory, took a deep dive into the value of having a veterinary business advisor when you are selling your practice.
• And more!